apretude - cabotegravir
(Cabotegravir)Viiv Healthcare Company
Usage: Apretude is used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test is required before starting.